Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 50.50 GBp
Change Today 0.00 / 0.00%
Volume 0.0
RXB On Other Exchanges
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

rex bionics plc (RXB) Snapshot

50.50 GBp
Previous Close
50.50 GBp
Day High
50.50 GBp
Day Low
50.50 GBp
52 Week High
09/1/14 - 181.50 GBp
52 Week Low
08/24/15 - 50.50 GBp
Market Cap
Average Volume 10 Days
-0.63 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for REX BIONICS PLC (RXB)

Related News

No related news articles were found.

rex bionics plc (RXB) Related Businessweek News

No Related Businessweek News Found

rex bionics plc (RXB) Details

Rex Bionics Plc engages in the research and development, manufacture, and commercialization of advanced robotic devices in New Zealand and internationally. The company offers its products to provide physiotherapy to and enhance the physical and psychological well-being of people with major mobility impairment as a result of spinal cord injury or other neurological damage. It provides REX, a hands-free, self-supporting, independently controlled robotic walking device for use in the rehabilitation of people with major mobility impairment; and REX P for use in the home that enables users to walk and stand with their hands free. The company was formerly known as Union MedTech Plc and changed its name to Rex Bionics Plc in May 2014. Rex Bionics Plc was incorporated in 2007 and is based in Thame, the United Kingdom.

Founded in 2007

rex bionics plc (RXB) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 76.0K GBP
Chief Financial Officer and Director
Total Annual Compensation: 142.0K GBP
Chief Technology Officer and Director
Total Annual Compensation: 156.0K GBP
Compensation as of Fiscal Year 2015.

rex bionics plc (RXB) Key Developments

Rex Bionics Plc Proposes Amendments to Articles of Association

Rex Bionics Plc at its General Meeting to be held on June 30, 2015, proposed Amendments to Articles of Association.

Rex Bionics Plc, Special/Extraordinary Shareholders Meeting, Jun 30, 2015

Rex Bionics Plc, Special/Extraordinary Shareholders Meeting, Jun 30, 2015., at 10:00 GMT Standard Time. Location: offices of Simmons & Simmons. Agenda: To consider each of the existing issued ordinary shares of £1 each in the share capital of the company is sub-divided and re-designated into one new ordinary share of 10 pence and one new deferred share of 90 pence in the share capital of the company; and to consider Articles of Association be amended by the addition of a new definition to Article 2.1 and a new Article 5.2 setting out the rights of the deferred shares.

Rex Bionics plc Announces the First Patient Treated in Rapper II Clinical Trial

Rex Bionics Plc announced that the first patient has been successfully treated in its RAPPER II (Robot-Assisted PhysiotheraPy Exercises with REX) clinical trial. RAPPER II is a 100 patient study designed to measure time taken for wheelchair users to mobilise in a REX, exercise regimen completion and the severity of injury that can safely be treated with a REX. The participants are wheelchair users with a spinal cord injury.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXB:LN 50.50 GBp 0.00

RXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥1,510 JPY +26.00
Ekso Bionics Holdings Inc $1.41 USD +0.04
Parker-Hannifin Corp $108.00 USD +1.02
ReWalk Robotics Ltd $8.59 USD +0.13
View Industry Companies

Industry Analysis


Industry Average

Valuation RXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REX BIONICS PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at